Anti-Human Endoglin (hCD105) Immunotoxin—Containing Recombinant Single Chain Ribosome-Inactivating Protein Musarmin 1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-Human Endoglin (hCD105) Immunotoxin—Containing Recombinant Single Chain Ribosome-Inactivating Protein Musarmin 1

Published:2016-06-10 Issue:6 Volume:8 Page:184
ISSN:2072-6651
Container-title:Toxins
language:en
Short-container-title:Toxins

Author:

Barriuso Begoña,Antolín Pilar,Arias F.,Girotti Alessandra,Jiménez Pilar,Cordoba-Diaz Manuel,Cordoba-Diaz Damián,Girbés Tomás

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Toxicology

Link

http://www.mdpi.com/2072-6651/8/6/184/pdf

Reference36 articles.

1. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

2. Immunotoxin therapy of cancer

3. Use of Ribosome-Inactivating Proteins from Sambucus for the Construction of Immunotoxins and Conjugates for Cancer Therapy

4. Prospects of bacterial and plant protein-based immunotoxins for treatment of cancer;Weidle;Cancer Genom. Proteom.,2014

5. Immunotoxins Constructed with Ribosome-Inactivating Proteins and their Enhancers: A Lethal Cocktail with Tumor Specific Efficacy

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opportunities and challenges for ribosome-inactivating proteins in traditional Chinese medicine plants;Toxicon;2023-10

2. Targeting the Transforming Growth Factor-beta Signaling Pathway in the Treatment of Gynecologic Cancer;Current Cancer Drug Targets;2023-01

3. Antibody-Drug Conjugates: Basic Concepts and Structures;Antibody-Drug Conjugates and Cellular Metabolic Dynamics;2023

4. Preparation of a novel EGFR specific immunotoxin and its efficacy of anti-colorectal cancer in vitro and in vivo;Clinical and Translational Oncology;2021-01-21

5. A double safety lock tumor-specific device for suicide gene therapy in breast cancer;Cancer Letters;2020-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3